Company: SRPT
Filing Date: 2025-12-08
Form Type: 8-K
Source: 0001193125-25-310588
Chunk: 1

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-12-08
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01.      Financial Statements and Exhibits.  

(d) Exhibits

  Exhibit      Description                                                                                                                              
  Number                                                                                                                                                
  10.1+        Omnibus Equity Award Agreement, dated as of December 7, 2025, between the Company and Douglas S. Ingram                                  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  104          The cover page from this Current Report on Form 8-K of Sarepta Therapeutics, Inc., formatted in Inline XBRL and included as Exhibit 101  

  Portions of this exhibit (indicated by asterisks) have been redacted pursuant to Item 601 of Regulation S-K because they are both not material and the registrant customarily and actually treats...  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                       Sarepta Therapeutics, Inc.                       
  Date: December 8, 2025      By:      /s/ Cristin L. Rothfuss                          
                                       Cristin L. Rothfuss